Managing highly distorted corneas with topography-guided treatment

Article

Topography-guided LASIK, used with a comprehensive eye scanner (Pentacam, Oculus), has been very successful in minimizing severe corneal distortions and offers reliable registration in most cases.

Topography-guided LASIK, used with a comprehensive eye scanner (Pentacam, Oculus), has been very successful in minimizing severe corneal distortions and offers reliable registration in most cases, according to John Kanellopoulos, MD, in private practice in New York City and Athens.

Dr. Kanellopoulos has been using topography-guided software (Allegretto Wave Topolyzer, WaveLight) for 5 years at his clinic in Athens to treat extreme primary and surgery-induced irregularities.

This experience has taught Dr. Kanellopoulos that topography-guided customized ablation may require nomogram manipulation to adjust sphere, as the topographer does not read the refractive error in the eye. He and his colleagues also have found that corneal cross-linking either before or after the procedure may be effective in stabilizing the iatrogenic ectasias of keratoconus and, in the future, may reduce the number of transplants necessary to treat keratoconus.

Dr. Kanellopoulos has used topography-guided custom ablation in cases such as enlargement of the optical zone in re-treatment of residual hyperopia and severe irregularities caused by contact lens scarring. The technique was also used in an eye that had undergone four LASIK recuts, one of which may have resulted in loss of a corneal sliver. In this instance, Dr. Kanellopoulos performed topography-guided PRK.

While it seems to be safe and effective, topography-guided ablation also is likely to raise debates about when it is most appropriately used.

"For someone who has this technology available to them, there are ethical questions such as whether there will be treatment of early ectasias in order to avoid a corneal transplant in the future," Dr. Kanellopoulos said.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.